As neurologic findings among patients with COVID-19 emerge, comparison to sequelae seen with other coronaviruses is instructive.
Obstructive Sleep Apnea and Hypertension Update: FDA Clears Phase 2 Trial of Lorundrostat, an Oral Aldosterone Synthase Inhibitor
Mineralys Therapeutics also expects topline data from its phase 2 study of lorundrostat for the treatment of uncontrolled hypertension or resistant hypertension when used as an add-on therapy.
Respiratory Tripledemic 2022-23: An Expert Recap
William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.
Novel Tool Predicts Onset Age of Cognitive Impairment and Alzheimer Dementia
The Florey Dementia Index showed robustness across different cohorts but more testing is needed, researchers reported.
Distress Signals: How to Help a Clinician Colleague in Need
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Rebekah Bernard, MD, a family physician and national speaker on physician wellness.
Annual Incidence of Dementia in US Will Double by 2060, Reaching 1 Million Cases
Annual incidence of dementia will double in White adults and triple among Black adults. The updated estimates place the lifetime risk of developing dementia after age 55 at 42%.
Minimal Distress Reported with Multi-Cancer Early Detection Testing: New Findings from PATHFINDER Trial
A new analysis of patient reported outcomes from the PATHFINDER study indicate the potential clinical benefit of early cancer detection.